Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Metal Protein-Attenuating Compound for PET Neuroimaging: Synthesis and Preclinical Evaluation of [11C]PBT2.

Krishnan HS, Bernard-Gauthier V, Placzek MS, Dahl K, Narayanaswami V, Livni E, Chen Z, Yang J, Collier TL, Ran C, Hooker JM, Liang SH, Vasdev N.

Mol Pharm. 2018 Feb 5;15(2):695-702. doi: 10.1021/acs.molpharmaceut.7b00936. Epub 2018 Jan 22.

PMID:
29298483
2.

Synthesis and preliminary PET imaging of 11C and 18F isotopologues of the ROS1/ALK inhibitor lorlatinib.

Collier TL, Normandin MD, Stephenson NA, Livni E, Liang SH, Wooten DW, Esfahani SA, Stabin MG, Mahmood U, Chen J, Wang W, Maresca K, Waterhouse RN, El Fakhri G, Richardson P, Vasdev N.

Nat Commun. 2017 Jun 8;8:15761. doi: 10.1038/ncomms15761.

3.

cGMP production of the radiopharmaceutical [18 F]MK-6240 for PET imaging of human neurofibrillary tangles.

Collier TL, Yokell DL, Livni E, Rice PA, Celen S, Serdons K, Neelamegam R, Bormans G, Harris D, Walji A, Hostetler ED, Bennacef I, Vasdev N.

J Labelled Comp Radiopharm. 2017 May 15;60(5):263-269. doi: 10.1002/jlcr.3496. Epub 2017 Mar 23.

PMID:
28185305
4.

Discovery of a Highly Selective Glycogen Synthase Kinase-3 Inhibitor (PF-04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET Neuroimaging.

Liang SH, Chen JM, Normandin MD, Chang JS, Chang GC, Taylor CK, Trapa P, Plummer MS, Para KS, Conn EL, Lopresti-Morrow L, Lanyon LF, Cook JM, Richter KE, Nolan CE, Schachter JB, Janat F, Che Y, Shanmugasundaram V, Lefker BA, Enerson BE, Livni E, Wang L, Guehl NJ, Patnaik D, Wagner FF, Perlis R, Holson EB, Haggarty SJ, El Fakhri G, Kurumbail RG, Vasdev N.

Angew Chem Int Ed Engl. 2016 Aug 8;55(33):9601-5. doi: 10.1002/anie.201603797. Epub 2016 Jun 29.

5.

Practical Radiosynthesis and Preclinical Neuroimaging of [11C]isradipine, a Calcium Channel Antagonist.

Rotstein BH, Liang SH, Belov VV, Livni E, Levine DB, Bonab AA, Papisov MI, Perlis RH, Vasdev N.

Molecules. 2015 May 26;20(6):9550-9. doi: 10.3390/molecules20069550.

6.

Iodonium ylide-mediated radiofluorination of 18F-FPEB and validation for human use.

Stephenson NA, Holland JP, Kassenbrock A, Yokell DL, Livni E, Liang SH, Vasdev N.

J Nucl Med. 2015 Mar;56(3):489-92. doi: 10.2967/jnumed.114.151332. Epub 2015 Feb 5.

7.

A concise radiosynthesis of the tau radiopharmaceutical, [(18) F]T807.

Shoup TM, Yokell DL, Rice PA, Jackson RN, Livni E, Johnson KA, Brady TJ, Vasdev N.

J Labelled Comp Radiopharm. 2013 Dec;56(14):736-40. doi: 10.1002/jlcr.3098. Epub 2013 Jul 24.

8.

Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane.

Spencer TJ, Biederman J, Madras BK, Dougherty DD, Bonab AA, Livni E, Meltzer PC, Martin J, Rauch S, Fischman AJ.

Biol Psychiatry. 2007 Nov 1;62(9):1059-61. Epub 2007 May 23.

9.

Dopamine transporter (DAT) inhibitors alleviate specific parkinsonian deficits in monkeys: association with DAT occupancy in vivo.

Madras BK, Fahey MA, Goulet M, Lin Z, Bendor J, Goodrich C, Meltzer PC, Elmaleh DR, Livni E, Bonab AA, Fischman AJ.

J Pharmacol Exp Ther. 2006 Nov;319(2):570-85. Epub 2006 Aug 2.

10.

Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro.

Madras BK, Xie Z, Lin Z, Jassen A, Panas H, Lynch L, Johnson R, Livni E, Spencer TJ, Bonab AA, Miller GM, Fischman AJ.

J Pharmacol Exp Ther. 2006 Nov;319(2):561-9. Epub 2006 Aug 2.

11.

Decreased striatal D1 binding as measured using PET and [11C]SCH 23,390 in patients with major depression with anger attacks.

Dougherty DD, Bonab AA, Ottowitz WE, Livni E, Alpert NM, Rauch SL, Fava M, Fischman AJ.

Depress Anxiety. 2006;23(3):175-7.

PMID:
16528700
12.

PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate.

Spencer TJ, Biederman J, Ciccone PE, Madras BK, Dougherty DD, Bonab AA, Livni E, Parasrampuria DA, Fischman AJ.

Am J Psychiatry. 2006 Mar;163(3):387-95.

PMID:
16513858
13.

Cerebellar vermis involvement in cocaine-related behaviors.

Anderson CM, Maas LC, Frederick Bd, Bendor JT, Spencer TJ, Livni E, Lukas SE, Fischman AJ, Madras BK, Renshaw PF, Kaufman MJ.

Neuropsychopharmacology. 2006 Jun;31(6):1318-26.

14.

Preparation and pharmacokinetics of 11C labeled stavudine (d4T).

Livni E, Berker M, Hillier S, Waller SC, Ogan MD, Discordia RP, Rienhart JK, Rubin RH, Fischman AJ.

Nucl Med Biol. 2004 Jul;31(5):613-21.

PMID:
15219280
15.

Non-amine-based dopamine transporter (reuptake) inhibitors retain properties of amine-based progenitors.

Madras BK, Fahey MA, Miller GM, De La Garza R, Goulet M, Spealman RD, Meltzer PC, George SR, O'Dowd BF, Bonab AA, Livni E, Fischman AJ.

Eur J Pharmacol. 2003 Oct 31;479(1-3):41-51.

PMID:
14612136
16.

Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model.

Brownell AL, Canales K, Chen YI, Jenkins BG, Owen C, Livni E, Yu M, Cicchetti F, Sanchez-Pernaute R, Isacson O.

Neuroimage. 2003 Oct;20(2):1064-75.

PMID:
14568476
17.

A novel method for noninvasive detection of neuromodulatory changes in specific neurotransmitter systems.

Alpert NM, Badgaiyan RD, Livni E, Fischman AJ.

Neuroimage. 2003 Jul;19(3):1049-60.

PMID:
12880831
18.

A second-generation 99m technetium single photon emission computed tomography agent that provides in vivo images of the dopamine transporter in primate brain.

Meltzer PC, Blundell P, Zona T, Yang L, Huang H, Bonab AA, Livni E, Fischman A, Madras BK.

J Med Chem. 2003 Jul 31;46(16):3483-96.

PMID:
12877586
19.

Radiolabeling and biodistribution of methyl 2-(methoxycarbonyl)-2-(methylamino) bicyclo[2.1.1] -hexane -5-carboxylate, a potential neuroprotective drug.

Yu M, NĂ¥gren K, Chen YI, Livni E, Elmaleh D, Kozikowski A, Wang X, Jokivarsi K, Brownell AL.

Life Sci. 2003 Aug 8;73(12):1577-85.

PMID:
12865097
20.

Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging.

Cicchetti F, Brownell AL, Williams K, Chen YI, Livni E, Isacson O.

Eur J Neurosci. 2002 Mar;15(6):991-8.

PMID:
11918659
21.

[(11)C, (127)I] Altropane: a highly selective ligand for PET imaging of dopamine transporter sites.

Fischman AJ, Bonab AA, Babich JW, Livni E, Alpert NM, Meltzer PC, Madras BK.

Synapse. 2001 Mar 15;39(4):332-42.

PMID:
11169784
23.

Detection of the effects of dopamine receptor supersensitivity using pharmacological MRI and correlations with PET.

Nguyen TV, Brownell AL, Iris Chen YC, Livni E, Coyle JT, Rosen BR, Cavagna F, Jenkins BG.

Synapse. 2000 Apr;36(1):57-65.

PMID:
10700026
24.

The diagnostic role of the in vitro drug-induced interferon-gamma release test in Stevens-Johnson syndrome.

Halevy S, Cohen AD, Livni E.

Int J Dermatol. 1999 Nov;38(11):835-40.

PMID:
10583616
25.

Detection of dopaminergic cell loss and neural transplantation using pharmacological MRI, PET and behavioral assessment.

Chen YI, Brownell AL, Galpern W, Isacson O, Bogdanov M, Beal MF, Livni E, Rosen BR, Jenkins BG.

Neuroreport. 1999 Sep 29;10(14):2881-6.

PMID:
10549790
26.
27.

Positron emission tomographic analysis of central dopamine D1 receptor binding in normal subjects treated with the atypical neuroleptic, SDZ MAR 327.

Christian BT, Babich JW, Livni E, Alpert NM, Bonab AA, Munconi L, Polinski R, Rubin RH, Fischman AJ.

Int J Mol Med. 1998 Jan;1(1):243-7.

PMID:
9852226
28.

Muscle protein synthesis by positron-emission tomography with L-[methyl-11C]methionine in adult humans.

Fischman AJ, Yu YM, Livni E, Babich JW, Young VR, Alpert NM, Tompkins RG.

Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):12793-8.

29.

Leukocytoclastic vasculitis induced by low-dose methotrexate: in vitro evidence for an immunologic mechanism.

Halevy S, Giryes H, Avinoach I, Livni E, Sukenik S.

J Eur Acad Dermatol Venereol. 1998 Jan;10(1):81-5.

PMID:
9552765
30.

Generalized pustular drug eruptions: confirmation by in vitro tests.

Lazarov A, Livni E, Halevy S.

J Eur Acad Dermatol Venereol. 1998 Jan;10(1):36-41.

PMID:
9552755
31.

In vivo PET imaging in rat of dopamine terminals reveals functional neural transplants.

Brownell AL, Livni E, Galpern W, Isacson O.

Ann Neurol. 1998 Mar;43(3):387-90.

PMID:
9506557
32.

The role of macrophage migration inhibition factor in toxic epidermal necrolysis.

Halevy S, Livni E.

Int J Dermatol. 1997 Oct;36(10):776-8. No abstract available.

PMID:
9372356
33.

Flow cytometry: is it the ultimate crossmatch technique in living donors?

Klein T, Shapira Z, Yussim A, Kfir B, Narinsky R, Luria D, Livni E.

Transplant Proc. 1997 Sep;29(6):2647-8. No abstract available.

PMID:
9290775
34.

Severe minocycline-induced eosinophilic pneumonia: extrapulmonary manifestations and the use of in vitro immunoassays.

Bentur L, Bar-Kana Y, Livni E, Finkelstein R, Ben-Izhak O, Keidar S, Bentur Y.

Ann Pharmacother. 1997 Jun;31(6):733-5.

PMID:
9184714
35.

Urticaria during triple therapy for Helicobacter pylori infection: clinical implications.

Delpre G, Livni E, Niv Y.

Dig Dis Sci. 1997 Apr;42(4):728-30. No abstract available.

PMID:
9125640
36.

Quantification of dopamine transporter density in monkeys by dynamic PET imaging of multiple injections of 11C-CFT.

Morris ED, Babich JW, Alpert NM, Bonab AA, Livni E, Weise S, Hsu H, Christian BT, Madras BK, Fischman AJ.

Synapse. 1996 Nov;24(3):262-72.

PMID:
8923667
37.

Evaluation of cerebral pharmacokinetics of the novel antidepressant drug, BMS-181101, by positron emission tomography.

Christian BT, Livni E, Babich JW, Alpert NM, Dischino DD, Ruediger E, Salazar DE, Ford NF, Fischman AJ.

J Pharmacol Exp Ther. 1996 Oct;279(1):325-31.

PMID:
8859010
38.

Serum-sickness-like reaction associated with minocycline therapy in adolescents.

Harel L, Amir J, Livni E, Straussberg R, Varsano I.

Ann Pharmacother. 1996 May;30(5):481-3.

PMID:
8740328
39.

Measurement of muscle protein synthesis by positron emission tomography with L-[methyl-11C]methionine.

Hsu H, Yu YM, Babich JW, Burke JF, Livni E, Tompkins RG, Young VR, Alpert NM, Fischman AJ.

Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):1841-6.

40.

Pharmacokinetics of [18F]fleroxacin in patients with acute exacerbations of chronic bronchitis and complicated urinary tract infection studied by positron emission tomography.

Fischman AJ, Livni E, Babich JW, Alpert NM, Bonab A, Chodosh S, McGovern F, Kamitsuka P, Liu YY, Cleeland R, Prosser BL, Correia JA, Rubin RH.

Antimicrob Agents Chemother. 1996 Mar;40(3):659-64.

41.

Contribution of class I HLA-A2 antigen in immune reactions.

Komlos L, Hart J, Klein T, Livni E, Notmann J, Vardimon D, Ben-Rafael Z, Halbrecht I.

Med Hypotheses. 1995 Jul;45(1):54-8.

PMID:
8524181
42.

Synthesis of a 11C-labeled NK1 receptor ligand for PET studies.

Livni E, Babich JW, Desai MC, Godek DM, Wilkinson RA, Rubin RH, Fischman AJ.

Nucl Med Biol. 1995 Jan;22(1):31-6.

PMID:
7735167
43.

Early recognition of rejections in kidney transplant recipients: applying tests for kidney-derived urinary antigens.

Limberg R, Koch C, Livni E, Shaharabani E, Shapira Z, Falkenberg FW.

Kidney Int Suppl. 1994 Nov;47:S97-100. No abstract available.

PMID:
7869679
44.

Tissue pharmacokinetics of fleroxacin in humans as determined by positron emission tomography.

Rubin RH, Livni E, Babich J, Alpert NM, Liu YY, Cleeland R, Prosser BL, Thom E, Fischman AJ.

Int J Antimicrob Agents. 1994 Jul;4 Suppl 2:S15-20.

PMID:
18611628
45.

Erythema multiforme and hypersensitivity myocarditis caused by ampicillin.

Garty BZ, Offer I, Livni E, Danon YL.

Ann Pharmacother. 1994 Jun;28(6):730-1.

PMID:
7919560
46.

Synthesis of [11C]dapoxetine.HCl, a serotonin re-uptake inhibitor: biodistribution in rat and preliminary PET imaging in the monkey.

Livni E, Satterlee W, Robey RL, Alt CA, Van Meter EE, Babich JW, Wheeler WJ, O'Bannon DD, Thrall JH, Fischman AJ.

Nucl Med Biol. 1994 May;21(4):669-75.

PMID:
9234326
47.

Myocardial extraction of 1-[11C] betamethylheptadecanoic acid.

Elmaleh DR, Livni E, Alpert NM, Strauss HW, Buxton R, Fischman AJ.

J Nucl Med. 1994 Mar;35(3):496-503.

48.

Distortion in the parental transmission of HLA-A2 haplotypes (locus A,B).

Komlos L, Livni E, Klein T, Halbrecht I, Hart J, Zaizov R.

Med Hypotheses. 1993 Dec;41(6):513-5.

PMID:
7514257
49.

Hyperprolactinaemia during famotidine therapy.

Delpre G, Lapidot M, Lipchitz A, Livni E, Kadish U.

Lancet. 1993 Oct 2;342(8875):868. No abstract available.

PMID:
8104296
50.

Pharmacokinetics of [18F]fleroxacin in healthy human subjects studied by using positron emission tomography.

Fischman AJ, Livni E, Babich J, Alpert NM, Liu YY, Thom E, Cleeland R, Prosser BL, Correia JA, Strauss HW, et al.

Antimicrob Agents Chemother. 1993 Oct;37(10):2144-52.

Supplemental Content

Support Center